ML281 from BOC Sciences

Supplier Page

Supplier Page from
BOC Sciences for
ML281

Description

ML281, a quinoxalin derivative, has been found to be a STK33 inhibitor and could have probable effect against KRAS-dependent cancers. IC50: 14 nM